Home
Conditions
Metastatic Colorectal Cancer (CRC)

Clinical trial condition

Metastatic Colorectal Cancer (CRC)

Explore clinical trials studying Metastatic Colorectal Cancer (CRC). Study availability and eligibility vary by location and protocol.

37 public trials 18 recruiting studies

Refine in advanced search Browse all conditions

Metastatic Colorectal Cancer (CRC) trial results

Not yet recruiting

A Biomarker Exploration Study for Predicting Localization of Recurrence and Metastasis in Colorectal Cancer (PROBE Study)

NCT07685236

Conditions: Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +9 more
Locations: Not specified

View Trial Details

Not yet recruiting

A Single-arm, Multicenter Clinical Study of Fruquintinib Combined With Serplulimab and Chemotherapy as First-line Treatment for Patients With RAS/BRAF-mutated Advanced Colorectal Cance

NCT07622550

Conditions: Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +9 more
Locations: Changzhou Tumor Hospital (Changzhou Fourth People's Hospital) Changzhou, Jiangsu, China

Liyang People's Hospital Changzhou, Jiangsu, China

The First People's Hospital of Changzhou Changzhou, Jiangsu, China

Huaian First People's Hospital Huai'an, Jiangsu, China

View all 16 locations

View Trial Details

Not yet recruiting

FOLFOX8 Versus mFOLFOX6 With Bevacizumab or Cetuximab for First-Line Unresectable Metastatic Colorectal Cancer (Phase II)

NCT07621497

Conditions: Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +9 more
Locations: Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

View Trial Details

Not yet recruiting

Study Evaluating the Safety Feasibility and Efficacy of ODI-2001 Vaccine, a Personnalized Immunotherapy in Patients With Metastatic or Locally Advanced Colon Cancer or Pancreatic Cancer

NCT07587827

Conditions: Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +16 more
Locations: CHRU Jean Minjoz Besançon, France

Centre Georges-François Leclerc Dijon, France

View Trial Details

Not yet recruiting

A Clinical Study of Liposomal Irinotecan for Second-Line Therapy in Metastatic Colorectal Cancer

NCT07585279

Conditions: Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +11 more
Locations: Fourth Hospital of Hebei Medical University Shijiazhuang, Hebei, China

View Trial Details

Not yet recruiting

A Clinical Study of Iparomlimab and Tuvonralimab Combined With Bevacizumab and Alternating Triweekly CAPOX/mCAPIRI Regimen as First-line Treatment for Unresectable Advanced Colorectal Cancer

NCT07446387

Conditions: Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +9 more
Locations: Jiangsu Cancer Hospital Nanjing, Jiangsu, China

View Trial Details

Not yet recruiting

A Clinical Study of Iparomlimab and Tuvonralimab Combined With Fruquintinib and Heterogeneous Radiotherapy Versus Fruquintinib as Third-Line and Subsequent-Line Treatment for Metastatic Colorectal Cancer

NCT07502014

Conditions: Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +10 more
Locations: Not specified

View Trial Details

Not yet recruiting

A Clinical Study on the Treatment of Metastatic Colorectal Cancer at the Second-line or Beyond.

NCT07395063

Conditions: Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +9 more
Locations: Not specified

View Trial Details

Not yet recruiting

Fruquintinib Combined With Trifluridine/Tipiracil Versus Bevacizumab Combined With Trifluridine/Tipiracil for Advanced Metastatic Colorectal Cancer

NCT07286695

Conditions: Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +10 more
Locations: Cancer Hospital Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China

View Trial Details

Not yet recruiting

A Phase II Clinical Study Evaluating SSGJ-706 in Combination Therapy for Advanced Gastrointestinal Cancers

NCT07233850

Conditions: Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +15 more
Locations: Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China

View Trial Details

Metastatic Colorectal Cancer (CRC)

Metastatic Colorectal Cancer (CRC) trial results

Related conditions